Is MicroLactin more effective than glucosamine?
On One Hand: Clinical Trials Indicate It Is More EffectiveMore that 16 clinical trials have been completed which indicate that MicroLactin is approximately 60 percent more effective than glucosamine in improving joint function. A 2002 clinical study published in Current Therapeutic Research yielded results which clearly showed MicroLactin’s effectiveness in relieving stiffness, immobility and pain associated with arthritis.On the Other: It Is Not FDA RegulatedThe United States Food and Drug Administration have not evaluated any of the claims made by manufacturers of MicroLactin. Additionally, no studies have been completed to evaluate the effects of MicroLactin on patients under age 20. Patients allergic to milk should not take this product.Bottom LineAvailable research indicates that MicroLactin is more effective than glucosamine in relieving arthritis pain in adults aged 20 and older; however, combining therapies may be the optimal answer for improved joint health.
